Subcutaneous Epcoritamab Induces Complete Responses with an Encouraging Safety Profile across Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma Subtypes, Including Patients with Prior CAR-T Therapy: Updated Dose Escalation Data

Martin Hutchings, Rogier Mous, Michael Roost Clausen, Peter Johnson, Kim M. Linton, Martine E.D. Chamuleau, David John Lewis, Anna Sureda Balari, David Cunningham, Roberto S. Oliveri, Dena DeMarco, Brian Elliott, Kuo-mei Chen, Pieternella J. Lugtenburg

Publikation: Bidrag til tidsskriftKonferenceabstrakt i tidsskriftForskningpeer review

OriginalsprogDansk
TidsskriftBlood
Vol/bind136
Udgave nummerSuppl. 1
Sider (fra-til)45-46
ISSN0006-4971
DOI
StatusUdgivet - 5. nov. 2020

Citationsformater